Review Article

Evolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?

Table 1

Characterization and comparison of different conventional biochemical and molecular tests to identify different Mycobacterium bovis (BCG) and Mycobacterium tuberculosis species.

Tests strain M. bovis BCG P3M. tuberculosis H37RvRemarks

Nitrate reductionNegativePositive¥
NiacinPositivePositive
CatalaseNegativeNegative
hsp65-PCRPositivePositive
esat6-PCRNegativePositive
Mac-PCRNegativeNegative
MPT64 antigenNegativePositive
MPT63 antigenPositivePositive
Binary spoligotyping■■□■■■■■□■■■■■■□■■■■■■■■■■■■■■■■■■■■■■□□□□□■■■■■■■■■■■■■■■■■■■□□■■■■■■■■■■■□□□□■■■■■■■
Octal number676773777777600777777477760771
Shared type482451
Lineage/sublineagesBovis1_BCGH37Rv

Guinea pig virulenceNon-virulentVirulentΨ

M. bovis BCG (Tokyo)M. tuberculosis H37Ra

Nitrate reductionPositivePositive [14]
NiacinPositivPositive
CatalaseNegativePositiv

M. bovis BCG (ATCC 19274), M. bovis BCG (Biken)M. tuberculosis H37Rv (TMC102), H37Rv (Biken), H37Ra (Biken)

Niacin testWeakly PositivePos [15]

BCG Copenhagen, BCG Glaxo, BCG Pasteur, BCG TiceM. tuberculosis H37Rv, M. tuberculosis H37Ra

MPB64NegativePositive [15]
MPB70PositivePositive
16SrRNAPositivePositive

BCG Tokyo, BCG Moreau, BCG Russia, BCG Sweden.  M. bovis AN5

MPB64Positive [16]
MPB70Positive
16SrRNAPositive

M. bovis BCG (Glaxo, Pasteur, Tice)M. tuberculosis (H37Rv)

MPB64NegativePositive [16]
IS6110 copy number1

M. bovis BCG (Brazilian, Japanese, Russian, Swedish)

MPB64Positive [16]
IS6110 copy number2

M. bovis BCG M. tuberculosis (classical)

Nitrate reduction PositivePositive [17]
NiacinNegativePositive

M. bovis BCG M. tuberculosis (classical)

Nitrate reductionNegativePositive [18]
NiacinNegativePositive
MPB70PositivePositive
Mtp40NegativePositiv (very occasionally)

M. bovis BCGM. tuberculosis

Nitrate reductionNegativePositive [19]
NiacinNegativePositive
MPB70PositiveNegative
Mtp40NegativePositive
Spoligotyping spacer 39–43NegativePositive

M. bovis M. tuberculosis

Nitrate reductionNegativePositive [20]
Niacin accumulationNegativePositive
Presence of mtp40NegativePositive
Spoligotype
(characteristic features)
At least one of spacers 39–43 presentSpacers 39–43 absent

M. bovis BCG M. tuberculosis (H37Rv)

Binary spoligotyping■■□□□■■■□■■■■■■□■■■■□■■■■■■■■■■■■■■■■■□□□□□■■■■■■■■■■■■■■■■■■■□□■■■■■■■■■■■□□□□■■■■■■■ [21]
Octal number616773677777600777777477760771
Shared type663451
BOVIS1H37Rv

M. bovis M. tuberculosis

Spacers 33 to 36
(derived from BCG)
M. tuberculosis does not hybridize to the spacers [22]
Spacers 39 to 43
(derived from M. tuberculosis)
M. bovis and BCG do not hybridize to the spacers

M. bovis M. tuberculosis (H37Rv)

Capilia TB-NeoPositivePositive [23]
SD MPT64PositivePositive
TbcIDPositivePositive

M. bovis BCG TokyoM. bovis BCG Connaught

Capilia TB-NeoPositiveNegative [23]

Our analysis on the Indian seed-lot; personal communication with the Director of the BCG vaccine producing laboratory; very occasionally positive; Weak Positive.